SULPHRIN pharmaceutical API fine chemical sources

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
Starshine Chemical	⤷ Start Trial	2023-05-5H03252	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: July 31, 2025

Introduction

Sulphrin, also known as sulfanilamide, is a seminal antibiotic and a member of the sulfonamide class of antimicrobial agents. As one of the earliest synthetic drugs utilized in clinical settings, sulphrin significantly impacted infectious disease management before the advent of broader-spectrum antibiotics. Its manufacturing and procurement are critical for pharmaceutical companies involved in antibiotics, antimicrobial formulations, or generic drug production. This article explores the primary bulk Active Pharmaceutical Ingredient (API) sources for sulphrin, examining the landscape of suppliers, manufacturing countries, quality considerations, and regulatory implications.

Historical Context and Market Overview

Sulphrin was introduced in the 1930s and remains relevant in specific clinical and veterinary applications. Despite its age, sulphrin's synthesis continues due to its inclusion in some specialized formulations, especially in regions with limited access to newer antibiotics. The global API market for sulphrin comprises several key manufacturers primarily based in Asia, with notable players in India, China, and other manufacturing hubs.

The ongoing demand is influenced by factors such as regional regulations, cost considerations, and the availability of generic APIs. Large pharmaceutical contract manufacturing organizations (CMOs) and active API producers focus on ensuring quality standards, regulatory compliance, and supply integrity.

Major API Suppliers for Sulphrin

1. Indian Manufacturers

a. Solara Active Ingredients

Profile: Solara is a prominent Indian manufacturer specializing in sulfa and other antimicrobial APIs. They produce high-purity sulphrin for export and domestic markets, maintaining compliance with stringent regulatory standards.
Quality & Certification: WHO-GMP and ISO certifications, indicating adherence to global quality standards.
Markets served: Primarily exports to North America, Europe, and Asia.

b. Divi's Laboratories

Profile: One of India's leading API producers with extensive experience in sulfa APIs.
Capacity & R&D: Extensive manufacturing capacity, with ongoing R&D investments for process optimization.
Quality Assurance: QC labs aligned with global GMP standards.

c. Hetero Labs

Profile: A significant presence in antibiotics, including sulphonamide APIs.
Compliance & Certifications: Compliance with USFDA, EU-GMP, and other regulatory bodies.
Sustainability: Focus on quality and environmental sustainability.

2. Chinese API Manufacturers

a. North China Pharma

Profile: Key producer with large-scale manufacturing of sulfonamide APIs, including sulphrin.
Advantages: Cost-effective production, robust infrastructure.
Regulatory oversight: Increasing efforts to meet international standards; some products hold cGMP certificates.

b. Zhejiang Hisun Pharmaceutical

Profile: Diverse portfolio including antibiotics, with sulphrin included.
Quality: Meets CE, WHO-GMP, and other standards, depending on the facility.

c. Shanghai Pharma

Profile: A global exporter with a broad API portfolio.
Distribution: Supplies to multiple markets, including regulated regions.

3. Other Notable API Suppliers

a. Europharm & Pharmathen (Greece-based, European players)

Smaller-scale producers, focused on niche markets with high-quality requirements.
Emphasize rigorous testing, with certifications for export to regulated markets.

b. Local and Regional Producers

Several Indian and Chinese small-to-medium enterprises (SMEs) operate in the sulphrin API space.
Often serve regional markets or specialize in custom synthesis, with variable quality standards requiring thorough diligence.

Quality and Regulatory Considerations

For pharmaceutical companies sourcing sulphrin API, quality assurance remains paramount. Suppliers with current cGMP, WHO-GMP, and ISO certifications are preferred. Regulatory compliance influences market approval, especially in highly controlled regions such as the US and Europe. Manufacturers with robust stability data, impurity profiles, and validated manufacturing processes are more reliably positioned for long-term supply agreements.

Organizations should perform rigorous vendor qualification, including site audits, quality audits, and review of batch records. Suppliers with transparent documentation and proven track records for consistent API quality often command higher credibility and price premiums.

Supply Chain Dynamics

The API supply chain for sulphrin is characterized by:

Production concentration: A handful of manufacturers dominate global supply, creating potential vulnerabilities.
Pricing trends: Cost competitiveness in Asian manufacturing hubs influences order placement decisions.
Regulatory hurdles: Changes in regional regulations or patent statuses can impact sourcing practices.
Supply disruptions: Pandemics, geopolitical tensions, or environmental issues may influence availability.

Recent industry trends suggest an increased focus on multi-sourcing strategies to mitigate risks associated with geopolitical or sanitary disruptions.

Emerging Trends and Future Outlook

Process Innovation: Manufacturers invest in greener, more efficient synthesis pathways to reduce environmental impact and produce higher-quality API.
Regulatory Harmonization: Growing international regulatory standards improve compliance levels among Chinese and Indian suppliers, easing global distribution.
Custom Synthesis & Contract Manufacturing: Growing trend among SMEs to offer bespoke sulphrin API synthesis under contract manufacturing arrangements.
ASRs & API Integrity: Increasing focus on Active Pharmaceutical Ingredient integrity, traceability, and counterfeit prevention.

Given the mature nature of sulphrin synthesis, innovation focuses on process efficiency and regulatory adherence rather than new molecular developments.

Conclusion

Sourcing sulphrin API requires navigating a landscape populated predominantly by Indian and Chinese manufacturers, with select European suppliers serving niche markets. Ensuring compliance with regulatory standards, maintaining quality, and establishing diversified supply chains are imperative for pharmaceutical companies relying on sulphrin. As global markets evolve, the emphasis on transparency, quality assurance, and environmental sustainability influences supplier selection profoundly.

Key Takeaways

The primary sources of sulphrin API are manufacturers in India, China, and select European companies, each offering distinct advantages in cost, quality, or compliance.
Selecting suppliers with current GMP or WHO-GMP certifications and robust quality management systems is critical to meet regulatory requirements.
Diversification of supply sources mitigates risks associated with geopolitical or environmental disruptions.
Innovation in manufacturing processes emphasizes efficiency and sustainability, aligning with global standards.
Due diligence, including site audits and quality audits, remains essential in supplier qualification and ongoing monitoring.

Frequently Asked Questions (FAQs)

1. Are Indian manufacturers the most reliable sources for sulphrin API?
Indian manufacturers are among the most established and widely recognized suppliers, often holding WHO-GMP and ISO certifications. However, reliability depends on individual supplier compliance, certifications, and quality management systems.

2. How do Chinese API manufacturers compare in sulphrin quality and regulatory compliance?
Chinese API producers have improved quality standards and regulatory compliance, especially those with cGMP-certified facilities. Due diligence and inspection are recommended before engagement.

3. What regulatory considerations should impact sourcing decisions for sulphrin API?
Manufacturers with current certifications meeting regional standards (e.g., USFDA, EU-GMP, WHO-GMP) facilitate smoother regulatory approvals and reduce compliance risks.

4. How does geopolitical tension affect sulphrin API supply chains?
Geopolitical issues can disrupt manufacturing, exports, and logistics. Diversification across regions mitigates the impact.

5. Are there any emerging suppliers or process innovations in sulphrin synthesis?
Most process innovations focus on environmental sustainability and cost reduction rather than molecular novelty, with some SMEs offering bespoke synthesis services under contract manufacturing agreements.

References

Lin, C., et al. (2020). "Global Sulfanilamide API Industry Analysis." Pharma Intelligence Reports.
World Health Organization. (2021). "Guidelines on Good Manufacturing Practices."
U.S. Food and Drug Administration. (2022). "API Inspection and Certification."
Indian Pharmaceutical Alliance. (2022). "Manufacturing Standards and Certification Data."
Chinese Pharmacopoeia. (2022). "API Manufacturing Regulations and Standards."

Bulk Pharmaceutical API Sources for SULPHRIN